Adaptogenics Health Corp. — Regulatory Filings 2022

Dec 14, 2022

Crowe

Crowe MacKay LLP
1100 - 1177 West Hastings Street
Vancouver, BC V6E 4T5
Main +1 (604) 687-4511
Fax +1 (604) 687-5805
www.crowemackay.ca

December 12, 2022

British Columbia Securities Commission

Dear Sirs/Mesdames:

Re: Adaptogenics Health Corp.

We refer to the final long-form prospectus of Adaptogenics Health Corp. (the "Company") dated December 12, 2022 (the "Final Prospectus") relating to the Company becoming a reporting issuer pursuant to applicable securities regulation in British Columbia.

We consent to being named and to the use, through inclusion in the above-mentioned Final Prospectus, of our report dated December 12, 2022 to the directors of the Company on the following financial statements:

• statement of financial position as at March 31, 2022;
• statements of loss and comprehensive loss, changes in shareholders' equity and cash flows for the year ended March 31, 2022; and
• notes to the financial statements, including a summary of significant accounting policies and explanatory information.

We report that we have read the Final Prospectus and all information specifically included therein and have no reason to believe that there are any misrepresentations in the information contained therein that are derived from the financial statements upon which we have reported or that are within our knowledge as a result of our audit of such financial statements. We have complied with Canadian generally accepted standards for an auditor's consent to the use of a report of the auditor included in an offering document, which does not constitute an audit or review of the prospectus as these terms are described in the CPA Canada Handbook – Assurance.

"Crowe MacKay LLP"

Chartered Professional Accountants
Vancouver, British Columbia